Seattle-based Calypso Medical Technologies announced today it has signed a strategic development agreement with Siemens Healthcare to jointly develop products for radiation therapy of pancreas and lung cancer, as well as prostate cancer. Financial details weren’t given. Calypso makes tracking technologies that help deliver pinpoint radiation to tumors. The company raised $50 million in September, and also has partnerships with Varian Medical Systems, Elekta, and Philips Medical.
via seattlepi.com
Posted via web from Avantrasara
Researchers – please visit our Clinical Research Hub page and register for our Clinical Research Collaboration Forum. Commercial organisations are invited to visit our Partners page. Press please contact Press.Office@avantrasara.com.
